For most of his career, P’damore has been an independent artiste who has recorded songs for independent producers in Jamaica ...

Smoking fish is as old as fishing itself. Some techniques, and of course equipment, have evolved since our ancestors first tied a line to a stick, but some universal truths remain as relevant as ever.

New 'Grumpy' Fish Species Discovered in the Red Sea Sep. 16, 2024 — Scientists have discovered a new species of fish, the 'grumpy dwarfgoby'. Found among coral reefs in the Red Sea, it has large ...

Investors with a lot of money to spend have taken a bearish stance on Cassava Sciences SAVA. And retail traders should know. We noticed this today when the trades showed up on publicly available ...

Barter trade is still practiced in Abotoase market in the Oti region, where locals exchange farm produce like maize and ...

Cassava Sciences and its executives agreed to pay $40 million in penalties for misleading investors. Dr. Wang, a consultant, manipulated clinical trial data, leading to misleading Alzheimer's ...

Alzheimer’s drug developer Cassava Sciences agreed Thursday to pay $40 million to settle regulatory claims that it misled investors about the results of a clinical trial that showed promise for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

What is FDA’s responsibility to Cassava’s patients? The SEC last week concluded that Cassava Sciences misled investors about its experimental Alzheimer’s drug. Now the FDA needs to act ...

For nearly a year, my stance on Cassava Sciences and its Alzheimer’s disease drug candidate simufilam has been clear: Emerging evidence shows the drug is inert, and patients with Alzheimer’s ...

Shares of Cassava Sciences Inc. dropped more than 12% in the extended session Thursday U.S. securities regulators announced a settlement with the pharma company, after charging it and two former ...

Shares of Cassava Sciences Inc. dropped more than 12% in the extended session Thursday after announcing a settlement with U.S. securities regulators, who had charged the pharma company and two ...